Thesis

Elucidating the Use of Epigenetic Drugs for Breast Cancer

---

Epigenetic modulator or epigenetic drug has shown promising potential as cancer therapeutic agents. In prostate cancer, inhibition of a histone methyltransferase (HMT) is able to induce IFN-JAK-STAT-mediated cell death. Previous RNA microarray data has shown that I3, an HMT inhibitor, and TSA, an HDAC inhibitor, treatment can upregulate various IFN-related genes. I3 and TSA were treated to various breast cancer cell lines for qPCR analysis. IFN-γ was then treated to the cells to observe the activation of its downstream signals through qPCR and cell viability analysis. Results showed that I3 and TSA treatment is able to upregulate IFNGR1 in HER2-positive cell line. Thus, upon IFN-γ stimulation, robust IFN-γ signaling is activated, leading to cell death in HER2-positive breast cancer cell lines. This implies that I3 and TSA hold a potential as an immunotherapy for HER2-positive breast cancer.

---

Availability

Detail Information

Series Title

-

Call Number

BM 19-008

Publisher

Jakarta : i3L., 2019

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

-

Specific Detail Info

-

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment